is saxenda tirzepatide vs Mounjaro Saxenda vs Zepbound: Which GLP-1

How often and at what dose do I take Wegovy for weight loss

te ofrece

Consultado el 27 de enero de 2026: Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease, Lily

Jang-Liaw, W

I often see this work well for individuals who are already doing many of the right thingseating well, moving their bodies, working on sleep and stressbut still feel weight-loss resistant. This slower, gentler dosing strategy can be a good fit for people with a history of GI issues like IBS or chronic constipation or who tend to be sensitive to medications in general

Zhan MM, et al